DBV Technologies (DBVT) Change in Account Payables (2020 - 2026)
DBV Technologies (DBVT) reported Change in Account Payables of -$500000.0 for Q1 2026, down 104.59% year-over-year from $10.9 million in Q1 2025, and down 133.33% on a QoQ basis from $1.5 million in Q4 2025.
DBV Technologies (DBVT) has 7 years of Change in Account Payables data on file, last reported at -$500000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 104.59% year-over-year to -$500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 72.57% YoY) and the FY2025 annual result came in at $15.8 million, up 5702.57% from the prior year.
- Change in Account Payables declined to -$500000.0 in Q1 2026 per DBVT's latest filing, from $1.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $10.9 million in Q1 2025 and bottomed at -$4.8 million in Q1 2024.
- The 5-year median for Change in Account Payables is $1.4 million (2024), against an average of $1.6 million.
- Peak annual rise in Change in Account Payables reached 23668.42% in 2023, while the deepest fall reached 786.15% in 2023.
- Tracing DBVT's Change in Account Payables over 5 years: stood at -$2.2 million in 2022, then soared by 400.0% to $6.7 million in 2023, then slumped by 79.76% to $1.4 million in 2024, then rose by 10.13% to $1.5 million in 2025, then slumped by 133.33% to -$500000.0 in 2026.
- Per Business Quant, the three latest DBVT Change in Account Payables figures stand at -$500000.0 (Q1 2026), $1.5 million (Q4 2025), and -$638000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2025 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | -638,000.00 |
| Sep 30, 2025 | -638,000.00 |
| Jun 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 4.02 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | -4.81 Mn |
| Mar 31, 2024 | -4.81 Mn |
| Dec 31, 2023 | 6.73 Mn |
| Dec 31, 2023 | 6.73 Mn |
| Sep 30, 2023 | -1.73 Mn |
| Sep 30, 2023 | -1.73 Mn |
| Jun 30, 2023 | -1.06 Mn |
| Jun 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | 4.48 Mn |
| Mar 31, 2023 | 4.48 Mn |
| Dec 31, 2022 | -2.24 Mn |
| Dec 31, 2022 | -2.24 Mn |
| Sep 30, 2022 | -195,000.00 |
| Sep 30, 2022 | -195,000.00 |
| Jun 30, 2022 | 5.91 Mn |
| Jun 30, 2022 | 5.91 Mn |
| Mar 31, 2022 | -19,000.00 |
| Mar 31, 2022 | -19,000.00 |
| Dec 31, 2021 | -424,000.00 |
| Dec 31, 2021 | -424,000.00 |
| Sep 30, 2021 | -3.97 Mn |
| Sep 30, 2021 | -3.97 Mn |
| Jun 30, 2021 | -598,000.00 |
| Jun 30, 2021 | -598,000.00 |
| Mar 31, 2021 | -2.57 Mn |
| Mar 31, 2021 | -2.57 Mn |
| Dec 31, 2020 | 1.68 Mn |
| Dec 31, 2020 | 1.68 Mn |
| Sep 30, 2020 | -8.45 Mn |
| Sep 30, 2020 | -8.45 Mn |
| Jun 30, 2020 | 4.90 Mn |
| Jun 30, 2020 | 4.90 Mn |
| Mar 31, 2020 | -3.21 Mn |
| Mar 31, 2020 | -3.21 Mn |